An Adverse Effect of BAL in a Case of Subacute Arsenical Polyneuritis, with Observations on Porphyrin Metabolism

Abstract
BRITISH anti-lewisite (BAL) was first developed by Peters and his co-workers1 for the treatment of arsenical war-gas poisoning. It soon became apparent, however, that this compound could be used in the treatment of arsenical poisoning in general.Clinically, BAL has been used most extensively in the therapy of arsenical dermatitis, but it has also been employed in the treatment of blood dyscrasias due to arsenic, post-arsenical jaundice, arsenical encephalopathy and various other manifestations of arsenical poisoning. With the exception of post-arsenical jaundice, good results have been reported with this drug.It is the purpose of this paper to present a . . .